impetigo
Jump to navigation
Jump to search
Introduction
Superficial infection involving the epidermis characterized by crusted erosions or ulcerations.
Etiology
- Staphylococcus aureus
- most commonly phage group 2, type 71
- etiologic agent of Staphylococcal scalded skin syndrome same
- Streptococcus pyogenes
- primary infection of superficial break in skin
- secondary infection of pre-exsiting dermatosis
- predisposing factors
- colonization of skin by S aureus & S pyogenes
- warm ambient temperature
- high humidity
- dermatosis (esp atopic dermatitis)
- precipitating factors
Epidemiology
- primary infections more common in children
- most common bacterial infection in chidren[10]
- secondary infections occur at any age
- common disorder, very contagious[3]
- 25% of patients are nasal carriers of S aureus
- acquired by person to person contact[2]
Pathology
- vesicle formation in subcorneal or granular layer
- acantholysis
- spongiosis
- perivascular infiltrate of neutrophils & lymphocytes in dermis
- gram positive cocci within neutrophils in vesicles
- elaboration of S aureus exotoxin (exfoliatin)[2]
- same toxin causes Staphylococcal scalded skin syndrome
Clinical manifestations
- durations of lesions: days to weeks
- variable pruritus
- non-bullous: small vesicles or pustules rupture resulting in erosions which become crusted
- bullous:
- crusts may be gold (honey-colored) to hemorrhagic
- lesions round or oval, 1-3 cm in size
- scattered, discrete lesions, may be larger confluent lesions
- satellite lesions occur by auto-inoculation
- itchy, raised, weeping patches with scaly borders that develop honey-colored crusts
- distribution:
- face, arms, legs, buttocks
- bullous: trunk, face, hands, intertriginous sites
- regional lymphadenopathy may be present
Laboratory
- Gram stain of lesion
- Gm+ cocci in chains & clusters within neutrophils
- wound culture can be obtained from blister fluid or exudative crust[2]
- complete blood count (CBC): +/- leukocytosis
- serology: anti-DNAse beta indicates prior group A Streptococcal infection
- biopsy
Complications
- also see ecthyma
- non suppurative complications of group A streptococci
Differential diagnosis
- non-bullous impetigo
- bullous impetigo
- erysipelas (group A streptococcus)
Management
- wash with soap & water & removal of crusts
- topical agents
- may be sufficient for limited disease of head & neck
- topical antibiotic after soaking of crusts
- benzoyl peroxide (prevention)
- systemic antibiotics for more extensive disease
- Staphylococcus aureus
- dicloxacillin 250-500 mg PO QID
- cephalexin
- amoxicillin clavulanate (Augmentin)
- 20 mg/kg/day divided TID for 10 days
- macrolides for penicillin-sensitive individuals
- erythromycin
- clarithromycin 250-500 mg PO BID for 10 days
- azithromycin 250 mg QD for 5-7 days
- clindamycin
- methicillin-resistant Staphylococcus aureus (MRSA)
- mupirocin ointment
- minocycline 100 mg PO BID for 10 days
- doxycycline 100 mg PO BID
- Bactrim DS 1-2 tabs QD
- ciprofloxacin 500 mg PO BID
- group A streptococcus (S pyogenes)
- penicillin VK 250 mg PO TID
- benzathine penicillin
- erythromycin 250-500 mg PO QID for 10 days
- cephalexin 250-500 mg QID for 10 days
- Staphylococcus aureus
- prognosis
- prevention
- reoccurence may occur because of failure to erradicate infection or reinfection from family member
- mupirocin to nares of patient & family members for 5 days
- benzoyl peroxide soap
More general terms
Additional terms
References
- ↑ Color Atlas & Synopsis of Clinical Dermatology, Common & Serious Diseases, 3rd ed, Fitzpatrick et al, McGraw Hill, NY, 1997, pg 604-609
- ↑ Jump up to: 2.0 2.1 2.2 2.3 2.4 2.5 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17, 18. American College of Physicians, Philadelphia 1998, 2009, 2012, 2017, 2018.
Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025 - ↑ Jump up to: 3.0 3.1 Geriatrics at your Fingertips, 13th edition, 2011 Reuben DB et al (eds) American Geriatric Society
- ↑ Jump up to: 4.0 4.1 Lewis LS, Steele RW (images) Medscape: Impetigo http://emedicine.medscape.com/article/965254-overview
- ↑ Jump up to: 5.0 5.1 DermNet NZ. Impetigo (images) http://www.dermnetnz.org/bacterial/impetigo.html
- ↑ Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014 Aug 15;90(4):229-35. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25250996 Free Article
- ↑ NEJM Knowledge+ Question of the Week. May 21, 2019 https://knowledgeplus.nejm.org/question-of-week/1657/
- ↑ Koning S, van der Sande R, Verhagen AP et al Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;1:CD003261. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22258953
- ↑ Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014 Aug 15;90(4):229-35. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25250996 Free Article
- ↑ Jump up to: 10.0 10.1 10.2 Elkston CA, Elkston DM Bacterial Skin Infections: More Than Skin Deep. Medscape. July 19, 2021 https://reference.medscape.com/slideshow/infect-skin-6003449
- ↑ Jump up to: 11.0 11.1 Kosar L, Laubscher T. Management of impetigo and cellulitis: simple considerations for promoting appropriate antibiotic use in skin infections. Can Fam Physician. 2017;63:615-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28807958
- ↑ Gahlawat G, Tesfaye W, Bushell M, et al. Emerging treatment strategies for impetigo in endemic and nonendemic settings: A systematic review. Clin Ther. 2021;43:986-1006. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34053699